QNCX — Quince Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Quince Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	99.9	134	107	90.2	75.1
Prepaid Expenses
Total Other Current Assets
Total Current Assets	106	138	112	93.7	77.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.33	1.1	1.43	0.684	0.619
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	124	189	133	104	168
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.89	17	14.2	3.07	9.57
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	8.89	17.2	14.6	3.32	82.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	115	172	119	101	85.1
Total Liabilities & Shareholders' Equity	124	189	133	104	168
Total Common Shares Outstanding